Argenx
ARGX
#535
Rank
A$62.43 B
Marketcap
A$1,006
Share price
-0.21%
Change (1 day)
6.81%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2025 (TTM): A$13.55

According to Argenx 's latest financial reports the company's current EPS (TTM) is A$12.91. In 2024 the company made an earnings per share (EPS) of A$20.25 an increase over its 2023 EPS that were of A-$7.51.

EPS history for Argenx from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$13.55-33.11%
2024A$20.25-369.77%
2023A-$7.51-60.46%
2022A-$18.9963.33%
2021A-$11.62-40.37%
2020A-$19.50183.47%
2019A-$6.88123.09%
2018A-$3.0854.93%
2017A-$1.9914.07%
2016A-$1.7413.05%
2015A-$1.54-36.34%
2014A-$2.42209.04%
2013A-$0.78-33.99%
2012A-$1.19185.59%
2011A-$0.42